Patents by Inventor Eugenia Migliavacca

Eugenia Migliavacca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods to predict risk of and to stratify sarcopenia and NAD deficiency
    Patent number: 11815515
    Abstract: The present invention relates in general to the field of muscle disease. In particular, the invention relates to a method for determining if a subject has sarcopenia or has an increased risk of developing sarcopenia. A method of predicting the responsiveness of said subject to nutritional intervention is also provided.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: November 14, 2023
    Assignees: University of Southampton, Agency for Science, Technology and Research
    Inventors: Jerome Feige, Keith Malcolm Godfrey, Neerja Karnani, Eugenia Migliavacca
  • COMPOSITIONS CONTAINING AMINO ACIDS AND METHODS OF USING SUCH COMPOSITIONS FOR TREATING SARCOPENIA
    Publication number: 20230131476
    Abstract: A composition contains one or more aromatic amino acids and optionally vitamin B6. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be in a form of a powder, a powdered stick, a capsule or a solution. The composition can be administered to an individual in need thereof orally or intravenously for preventing and/or treating sarcopenia, a loss of and/or improving skeletal muscle mass, lean muscle mass, skeletal muscle strength and/or skeletal muscle function.
    Type: Application
    Filed: April 1, 2021
    Publication date: April 27, 2023
    Inventors: CLAUDIA ROESSLE, DENIS BREUILLE, EUGENIA MIGLIAVACCA, JEROME FEIGE
  • METHODS TO PREDICT RISK OF AND TO STRATIFY SARCOPENIA AND NAD DEFICIENCY
    Publication number: 20210072258
    Abstract: The present invention relates in general to the field of muscle disease. In particular, the invention relates to a method for determining if a subject has sarcopenia or has an increased risk of developing sarcopenia. A method of predicting the responsiveness of said subject to nutritional intervention is also provided.
    Type: Application
    Filed: January 14, 2019
    Publication date: March 11, 2021
    Inventors: Jerome Feige, Keith Malcolm Godfrey, Neerja Karnani, Eugenia Migliavacca
  • BIOMARKERS OF BLOOD-BRAIN BARRIER DYSFUNCTION
    Publication number: 20190346459
    Abstract: A method for determining whether a subject has an impaired blood-brain barrier (BBB) or is at risk of developing an impaired blood-brain barrier (BBB) comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers comprise serum amyloid A (SAA).
    Type: Application
    Filed: June 22, 2017
    Publication date: November 14, 2019
    Inventors: Gene Bowman, Loic Dayon, Eugenia Migliavacca, Julius Popp
  • METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR
    Publication number: 20110076283
    Abstract: The present invention relates to a method for predicting or diagnosing outcome of concomitant chemo-radiotherapy of a subject suffering from brain tumor. The present invention further relates to compositions and methods for treatment or prevention of tumor resistance in a subject suffering from a brain tumor and to a kit useful for predicting or diagnosing the tumor resistance in a subject treated with concomitant chemo-radiotherapy.
    Type: Application
    Filed: January 23, 2009
    Publication date: March 31, 2011
    Applicant: Universite De Lausanne
    Inventors: Monika Hegi, Anastasia Murat, Eugenia Migliavacca, Roger Stupp